Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance
Gina Leisching(Stellenbosch University), Anna‐Mart Engelbrecht(Stellenbosch University)
Cited by 39
Related Papers
Decreased Efficacy of Doxorubicin Corresponds With Modifications in Lipid Metabolism Markers and Fatty Acid Profiles in Breast Tumors From Obese vs. Lean Mice
|Frontiers in Oncology|2020|39